桂枝茯苓胶囊治疗寒凝血瘀型痛经大鼠的代谢组学研究
该研究采用苯甲酸雌二醇联合缩宫素构建寒凝血瘀型痛经大鼠模型,观察桂枝茯苓胶囊的抗痛经作用并用代谢组学探讨机制。结果显示桂枝茯苓胶囊可减少扭体次数、升高PGE2与β-EP、降低PGF2α,缓解子宫内膜增生并改善卵巢功能;其作用可能与下调COX-2表达、抑制花生四烯酸转化为前列腺素有关。
要点
- 桂枝茯苓胶囊可减少痛经大鼠扭体次数,升高血清PGE2和β-EP、降低PGF2α。
- 桂枝茯苓胶囊可缓解子宫内膜增生并改善卵巢功能。
- 其抗痛经机制可能与下调COX-2、抑制花生四烯酸转化为前列腺素有关。
核心结论
- 桂枝茯苓胶囊可有效缓解原发性痛经,其作用可能归因于对花生四烯酸-前列腺素代谢途径的调节。
研究设计与样本
- 采用苯甲酸雌二醇致敏联合缩宫素疼痛构建寒凝血瘀型痛经大鼠模型,观察桂枝茯苓胶囊的抗痛经作用并进行代谢组学分析。
主要发现
- 桂枝茯苓胶囊可显著减少痛经大鼠扭体次数,升高血清PGE2和β-EP水平,降低PGF2α含量。
- 子宫和卵巢病理切片显示桂枝茯苓胶囊可显著缓解子宫内膜增生并改善卵巢功能。
- 基于LC/MS的大鼠子宫代谢组学显示模型组与对照组偏离较大,桂枝茯苓胶囊组有向对照组回归的趋势,主要代谢变化集中在饱和与不饱和脂肪酸。
- 花生四烯酸处于关键地位,模型组其限速酶COX-2表达显著上调,桂枝茯苓胶囊干预后显著降低。
临床怎么用
- 桂枝茯苓胶囊对寒凝血瘀型原发性痛经可能通过抗炎及调节花生四烯酸代谢发挥疗效,可作为该证型痛经的选方参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dysmenorrhea refers to a kind of uterine cramping pain that occurs in women during the period of menstrual. Guizhi Fuling Capsules are mainly used for the treatment of various pain syndromes and especially effective in treating primary dysmenorrhea. However, the research on its modern pharmacology and mechanism of action have not been thoroughly carried out. It is not clear about the main active ingredients, potential targets and metabolic pathways involved in its efficacy. Therefore, this research project employed estradiol benzoate sensitization combined with oxytocin pain to construct the cold coagulation syndrome dysmenorrhea model, observed the anti-dysmenorrhea effect of Guizhi Fuling Capsules, and used the metabolomics to explore its mechanism. The results showed that Guizhi Fuling Capsules could considerably reduce the number of writhing times in dysmenorrhea rats, increasing the level of PGE2 and β-EP and reducing the contents of PGF2α in rat serum. Pathological sections of uterus and ovaries also showed that Guizhi Fuling Capsules could significantly relieve endometrial hyperplasia and improve ovarian function. The LC/MS-based metabolomics of rat uterine indicated that the model group has a great deviation from the control group. Compared with the model group, the Guizhi Fuling Capsules group had a tendency to shift to the control group, and the main metabolic changes was mainly concentrated on saturated and unsaturated fatty acids. Among them, arachidonic acid is in a pivotal position, and the expression of its rate-limiting enzyme (COX-2) involved in its cyclooxygenase metabolic pathway was significantly up-regulated in the model group, but significantly decreased after the intervention of Guizhi Fuling Capsules. In conclusion, Guizhi Fuling Capsules can effectively relieve primary dysmenorrhea, and this effect may be attributed to the regulation effects of Guizhi Fuling Capsules on endogenous metabolism, such as inhibiting arachidonic acid converted to prostaglandins through downregulate the expression of COX-2, which plays an anti-inflammatory effect.
引用
- Zhang Y, Su N, Liu W, et al. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea. Front Pharmacol. 2021. PMID: 34776980. doi:10.3389/fphar.2021.764904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。